Interstitial pneumonitis induced by bicalutamide and leuprorelin acetate for prostate cancer.
Maximal androgen blockade therapy is the standard endocrine treatment for advanced prostate cancer. We report here an unusual case of interstitial pneumonitis induced by bicalutamide and/or leuprorelin acetate treatment for metastatic prostate cancer.